ARCHIVES

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

This article is from The Cancer Letter archive.

Vol. 32 No. 46 | December 22, 2006

Download PDF Visit The Full Archive

Related Articles

GAO Suggests No Limit On Indirect Costs But Ceiling On Total Costs

September 7, 1979

Study: Negative HPV Test More Accurate than Negative Pap Test In Predicting Cervical Cancer Risk

July 25, 2014

Administration Seeks Increase In FDA Budget.

June 13, 2008

In Brief: Boutwell Declines Nomination to New NCAB Term; Rowley Again Urges Appointment Of Scientists

January 20, 1984

Options For Changes, Some Drastic, In Cooperative Groups Suggested By CTEP

April 11, 1986

ACS Announces New Awards for Nurses

October 30, 1987